ORKIDS

University of North Carolina at Chapel Hill

Description

The main purpose of this research is to investigate whether treatment with Krill Phospholipids Concentrate (AKBM-3031) also known as Krill Oil is able to replenish the omega-3 deficiency associated with Systemic Lupus Erythematous (SLE). Omega-3 is an essential nutrient that is important in preventing and managing heart disease. In addition, this study is also being done to determine whether taking the Krill Oil has further positive effects in SLE patients with regards to slowing down the progression of and/or preventing disease flares. SLE is a disease that affects the immune system and can affect any part of the body (skin, joints, and/or organs).

Not eligible if: Have rapidly progressive neurologic or renal disease. Using an omega-3 prescription drug (e.g. Lovaza®, Vascepa®, etc.) or as medical food (e.g. Vascazen®, Vayarin, Onemia™ etc.) or present or recent daily use of any over the counter fish oil or krill oil or any long-chain omega-3 fatty acid dietary supplement. Require anti-coagulation medication, such as coumadin, clopidogrel, dalteparin, dypyridamole, enoxaparin, heparin or ticlopidine.

Number of Visits

» 8 In person visit(s)

1 screening, 7 clinic

» 6 Remote visit(s)

6 phone

Participation Period

48 weeks

Compensation

$50 per completed visit

By clicking I am interested, your contact information will be sent to the researcher/study coordinator for this study. The coordinator will respond by email with additional information on how to proceed.